Originally Posted by
Minerbarejet
The last couple of years will have been just as difficult for PEB as the rest of the world.
Perhaps even more so when you recognize that the age group mostly involved with bladder cancer, ie: the elderly, are the ones also at the front of the firing line with Covid.
I cant see someone on the receiving end of a cytokine storm in their lungs as being too worried about keeping up with his/her/undecided bladder cancer monitoring regime or blood in their urine.
For anyone to vaguely consider that it has been "business as usual" and planned results should be forthcoming according to their own time scale parameters obviously havent been giving much credence to the impact of Covid.
The medical fraternity was blasted with this and had arguably the biggest disruption of all.
If a third of your workforce is off with Covid,(as an example), workplaces, research, medical centres and hospitals are shutdown or in lockdown and unapproachable I think it is pretty commendable to make any progress whatsoever.
A lack of interaction at conference level with the AUA hasnt helped either and most hospitals have been diverting resources elsewhere.
PEB would appear to be ideally placed to take advantage of any return to "normalcy" and I think we are seeing the start of any upsurge with the latest announcements rather than the rear view mirror reflections based entirely on the Annual Report.